FLUOCINOLONE ACETONIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for fluocinolone acetonide and what is the scope of patent protection?
Fluocinolone acetonide
is the generic ingredient in seventeen branded drugs marketed by Alpharma Us Pharms, Allied, Cosette, Fougera Pharms Inc, Invatech, Perrigo New York, Pharmafair, Taro, Usl Pharma, Allergan Herbert, Savage Labs, Medimetriks Pharms, Alimera Sciences Inc, Bausch And Lomb, Hill Dermac, Patrin, Amneal, Lyne, Padagis Israel, Quagen, Saptalis Pharms, Tasman Pharma, Glenmark Pharms Ltd, Novel Labs Inc, Pharmaderm, Galderma Labs Lp, Actavis Labs Ut Inc, Chartwell Rx, Encube Ethicals, Lupin, and Pai Holdings Pharm, and is included in seventy-nine NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Fluocinolone acetonide has one hundred and seventy-seven patent family members in twenty-seven countries.
There are eleven drug master file entries for fluocinolone acetonide. Twenty-four suppliers are listed for this compound.
Summary for FLUOCINOLONE ACETONIDE
International Patents: | 177 |
US Patents: | 2 |
Tradenames: | 17 |
Applicants: | 31 |
NDAs: | 79 |
Drug Master File Entries: | 11 |
Finished Product Suppliers / Packagers: | 24 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Clinical Trials: | 33 |
Patent Applications: | 6,845 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for FLUOCINOLONE ACETONIDE |
What excipients (inactive ingredients) are in FLUOCINOLONE ACETONIDE? | FLUOCINOLONE ACETONIDE excipients list |
DailyMed Link: | FLUOCINOLONE ACETONIDE at DailyMed |
Recent Clinical Trials for FLUOCINOLONE ACETONIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institutes of Health (NIH) | Phase 3 |
National Eye Institute (NEI) | Phase 3 |
Jaeb Center for Health Research | Phase 3 |
Pharmacology for FLUOCINOLONE ACETONIDE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for FLUOCINOLONE ACETONIDE
US Patents and Regulatory Information for FLUOCINOLONE ACETONIDE
Expired US Patents for FLUOCINOLONE ACETONIDE
International Patents for FLUOCINOLONE ACETONIDE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Slovenia | 2233112 | ⤷ Try a Trial | |
South Korea | 20050118161 | SUSTAINED RELEASE AND METHOD FOR OCULAR DELIVERY OF ADRENERGIC AGENTS | ⤷ Try a Trial |
Argentina | 047552 | SISTEMAS DE SUMINISTRO DE FARMACOS DE LIBERACION SOSTENIDA BIODEGRADABLES | ⤷ Try a Trial |
Japan | 2011093944 | BIODEGRADABLE SUSTAINED RELEASE DRUG DELIVERY SYSTEM | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2005051234 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 2005000268 | ⤷ Try a Trial | |
Taiwan | I496597 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FLUOCINOLONE ACETONIDE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2233112 | 122014000063 | Germany | ⤷ Try a Trial | PRODUCT NAME: FLUOCINOLONACETONID; NAT. REGISTRATION NO/DATE: 82809.00.00 20120720; FIRST REGISTRATION: GB PL 27813/0001 20120504 |
2233112 | 132014902285293 | Italy | ⤷ Try a Trial | PRODUCT NAME: FLUOCINOLONE ACETONIDE(ILUVIEN); AUTHORISATION NUMBER(S) AND DATE(S): 042616019, 20140530;PL27813/0001, 20120504 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.